Mole crowdsourcing: There could be an app for that

December 17, 2013 by Jana Cunningham, University of Utah
Study participants looking at images of moles to determine if they look suspicious or not. Credit: Jakob Jensen

Have you ever had a strange mole on your body and wondered if it was skin cancer? The best move is to schedule an appointment with a dermatologist, but many wait without realizing they could be dealing with melanoma.

Researchers at two universities – the University of Utah and Texas Tech University – have recently identified a new technique for handling this problem: Ask a crowd.

For their study, researchers showed 500 adult participants high-resolution images of 40 moles (nine of which were clinically-diagnosed melanomas) and asked individuals to circle those they found suspicious.

Although the average individual was only able to identify approximately half of the melanomas, researchers found that when looking at the group collectively, 19 percent of the participants were able to correctly identify 90 percent of the melanomas.

"Individuals are bad at finding cancerous moles," said University of Utah communication assistant professor, Jakob Jensen, senior author of the study published in the December issue of Cancer Epidemiology. "Our research shows that groups of people – when looked at as a group – are very good at this task. We call this process collective effort."

Collective effort can be effective even when a single person has low reliability at a task, as the pattern of the group overcomes the limitations of each individual. Collective effort does not utilize group decision making as respondents independently perform each task.

Jensen and colleagues refer to their collective effort approach as "mole crowdsourcing." Crowdsourcing is a popular term that refers to using crowds of people, often recruited online, to accomplish tasks.

"Mole crowdsourcing could be implemented via modern communication technology," added Jensen. "For instance, our research team is already working on a cell phone application that will allow people to take a photo of a and have that image evaluated by hundreds, if not thousands, of other users."

Mole crowdsourcing would not replace the importance of clinical skin examinations; rather, it would provide an evidence-based strategy for funneling high-risk patients toward those resources.

In the U.S., melanoma has been steadily increasing over the last 30 years. The five-year survival rate for late-stage melanoma is only 15 percent with approximately one person dying of this illness every 61 minutes in the United States. Five-year survival rates for improve dramatically if the cancer is caught before it advances to a late stage. Thus, finding suspicious moles early and motivating individuals to act is essential.

Explore further: Stage III/IV melanoma patients at risk for new primaries

Related Stories

Stage III/IV melanoma patients at risk for new primaries

December 10, 2013
(HealthDay)—Patients with stage III or IV melanoma who have not received treatment with BRAF inhibitors remain at risk for developing new primary melanomas (NPMs), although the incidence rates are lower than those observed ...

Some hair professionals report looking for skin cancer lesions on customers' scalp, neck and face

October 17, 2011
In a survey of hair professionals, some reported that they look at customers' face, scalp and neck for suspicious skin lesions, according to a report in the October issue of Archives of Dermatology.

AAD: Older men should screen themselves for skin cancer

March 1, 2013
(HealthDay)—Men aged 50 years or older are more likely to be diagnosed with invasive melanoma by a dermatologist than to detect it themselves; and they are less likely to seek a skin cancer screening due to a suspicious ...

As summer approaches, experts offer tips on preventing skin cancer

May 26, 2013
(HealthDay)—Memorial Day weekend is the unofficial start of summer, and experts note that you need to protect your skin while spending time in the sun.

Recommended for you

Existing treatment could be used for common 'untreatable' form of lung cancer

June 21, 2018
A cancer treatment already approved for use in certain types of cancer has been found to block cell growth in a common form of lung cancer for which there is currently no specific treatment available.

Researchers uncover new target to stop cancer growth

June 21, 2018
Researchers at the University of Wisconsin-Madison have discovered that a protein called Munc13-4 helps cancer cells secrete large numbers of exosomes—tiny, membrane-bound packages containing proteins and RNAs that stimulate ...

Novel therapy makes oxidative stress deadly to cancer

June 21, 2018
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

New therapeutic opportunity for the treatment of resistant malignant melanoma

June 21, 2018
A team of researchers led by Dr. Pierre Close, WELBIO researcher at the ULiège GIGA Institute and Dr. Francesca Rapino has uncovered a new therapeutic opportunity in the treatment of malignant melanoma that has acquired ...

New treatment helps avoid deafness in child chemotherapy patients

June 21, 2018
An international trial has found that a medicine commonly used to treat poisoning is effective in reducing deafness in children receiving chemotherapy for cancer.

Biologists discover how pancreatic tumors lead to weight loss

June 20, 2018
Patients with pancreatic cancer usually experience significant weight loss, which can begin very early in the disease. A new study from MIT and Dana-Farber Cancer Institute offers insight into how this happens, and suggests ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.